.

.

GTC at ASH 2021

GTC is excited to be exhibiting at ASH for the first time and look forward to meeting people in person.  Our booth # 3440 and would like you will stop by and say hello.  

If you would like to schedule a meeting fill out the form below 

    Human Verification

    We have four abstracts being presented at ASH – here is the schedule below.  

    1. 

    2892 Bone Marrow-Based Biomarkers for Predicting aGVHD Using Targeted RNA Next Generation Sequencing and Machine Learning 

    Program: Oral and Poster Abstracts 
    Session: 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II 
    Hematology Disease Topics & Pathways: 
    Translational Research 

    Sunday, December 12, 2021, 6:00 PM-8:00 PM 

    Maher Albitar, MD1*, Hong Zhang, PhD1*, Andrew L. Pecora, MD2*, Andrew Ip, MD, MSc3, Andre H. Goy, MD4*, Spiraggelos Antzoulatos1*, Ivan De Dios, BS1*, Wanlong Ma1*, Sukhdeep Kaur, MD5*, Hyung C. Suh, MD, PhD5*, Michele L. Donato, MD5* and Scott D. Rowley, MD6 

    2. 

    1828 Reliability of Liquid Biopsy and Next Generation Sequencing in Monitoring Residual Disease Post-Hematopoietic Stem Cell Transplant 

    Program: Oral and Poster Abstracts 
    Session: 723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster I 
    Hematology Disease Topics & Pathways: 
    Translational Research 

    Saturday, December 11, 2021, 5:30 PM-7:30 PM 

    Maher Albitar, MD1*, Hong Zhang, PhD1*, Andrew L. Pecora, MD2*, Andrew Ip, MD, MSc3, Andre H. Goy, MD, MS4*, Jeffrey Justin Estella, BS, MS1*, Ivan De Dios, BS1*, Wanlong Ma1*, Sukhdeep Kaur, MD5*, Hyung C. Suh, MD, PhD5*, Michele L. Donato, MD5* and Scott D. Rowley, MD6 

    3. 

    2395 Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms 

    Program: Oral and Poster Abstracts 
    Session: 621. Lymphomas: Translational—Molecular and Genetic: Poster II 
    Hematology Disease Topics & Pathways: 
    Clinically Relevant 

    Sunday, December 12, 2021, 6:00 PM-8:00 PM 

    Maher Albitar, MD1*, Hong Zhang, PhD1*, Andre H. Goy, MD, MS2*, Zijun Xu-Monette, PhD3*, Govind Bhagat, M.D.4, Carlo Visco, MD5*, Alexandar Tzankov, MD6*, Xiaosheng Fang3*, Feng Zhu7*, Karen Dybkaer, PhD, MSC8*, April Chiu, MD9*, Wayne Tam, MD, PhD10, Youli Zu, MD, PhD11*, Eric D. Hsi, MD12, F. B. Hagemeister, MD13, Jooryung Huh14*, Maurilio Ponzoni, MD15, Andrés J M Ferreri, MD16, Michael Moller17*, Benjamin M Parsons, DO18, Joannes H.J.M. Van Krieken, PhD, MD19*, Miguel Angel Piris20*, Jane N. Winter, MD21, Yong Li22*, Bing Xu, MD, PhD23* and Ken H. Young24 

    4.  

    3463 Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms 

    Program: Oral and Poster Abstracts 
    Session: 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III 
    Hematology Disease Topics & Pathways: 
    Translational Research 

    Monday, December 13, 2021, 6:00 PM-8:00 PM 

    Maher Albitar, MD1*, Andrew Ip, MD, MSc2, Andre H. Goy, MD3*, Jeffrey Justin Estella, BS, MS1*, Ivan De Dios, BS1*, Wanlong Ma1*, Andrew L. Pecora, MD4*, Jamie Koprivnikar, MD5* and James K McCloskey, MD5 

    You might be interested in …